Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin transporter (SERT) allosteric site is a regulatory region on the SERT protein, distinct from the primary substrate binding site. Located within the extracellular vestibule, it is primarily formed by transmembrane helices TM10–TM12 and extracellular loop 6 (EL6). Binding of ligands at this allosteric site modulates SERT function, influencing both substrate transport and inhibitor binding kinetics. Ligands such as serotonin and certain antidepressants can occupy this site, affecting the efficacy and duration of SSRIs and providing avenues for the development of novel antidepressants.
Allosteric modulation of serotonin transporter activity, influencing substrate transport and inhibitor binding kinetics.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Transporter Allosteric Site (SERT Allosteric Site).